NDSI
ABBV icon

Newman Dignan & Sheerar Inc’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$750K Buy
4,040
+5
+0.1% +$928 0.17% 98
2025
Q1
$845K Buy
4,035
+150
+4% +$31.4K 0.23% 85
2024
Q4
$690K Sell
3,885
-45
-1% -$8K 0.18% 99
2024
Q3
$745K Buy
3,930
+20
+0.5% +$3.79K 0.18% 98
2024
Q2
$671K Sell
3,910
-20
-0.5% -$3.43K 0.17% 104
2024
Q1
$716K Sell
3,930
-39
-1% -$7.1K 0.19% 100
2023
Q4
$615K Buy
+3,969
New +$615K 0.19% 103
2023
Q3
Sell
-4,020
Closed -$542K 165
2023
Q2
$542K Sell
4,020
-270
-6% -$36.4K 0.17% 111
2023
Q1
$684K Sell
4,290
-50
-1% -$7.97K 0.22% 96
2022
Q4
$701K Buy
4,340
+39
+0.9% +$6.3K 0.23% 96
2022
Q3
$577 Buy
4,301
+89
+2% +$12 0.09% 100
2022
Q2
$645K Sell
4,212
-50
-1% -$7.66K 0.22% 100
2022
Q1
$691 Buy
4,262
+375
+10% +$61 0.13% 100
2021
Q4
$526K Sell
3,887
-20
-0.5% -$2.71K 0.16% 110
2021
Q3
$421K Hold
3,907
0.12% 116
2021
Q2
$440K Sell
3,907
-30
-0.8% -$3.38K 0.15% 116
2021
Q1
$426K Hold
3,937
0.15% 114
2020
Q4
$422 Sell
3,937
-300
-7% -$32 0.07% 108
2020
Q3
$371K Buy
4,237
+606
+17% +$53.1K 0.16% 109
2020
Q2
$349K Buy
3,631
+480
+15% +$46.1K 0.15% 108
2020
Q1
$258K Sell
3,151
-405
-11% -$33.2K 0.14% 123
2019
Q4
$315 Hold
3,556
0.03% 128
2019
Q3
$269K Sell
3,556
-100
-3% -$7.57K 0.13% 132
2019
Q2
$266 Hold
3,656
0.01% 148
2019
Q1
$295K Sell
3,656
-390
-10% -$31.5K 0.12% 126
2018
Q4
$373 Hold
4,046
0.03% 107
2018
Q3
$382K Buy
4,046
+73
+2% +$6.89K 0.17% 115
2018
Q2
$368 Hold
3,973
0.02% 115
2018
Q1
$365K Buy
3,973
+343
+9% +$31.5K 0.18% 117
2017
Q4
$351K Sell
3,630
-375
-9% -$36.3K 0.18% 122
2017
Q3
$356K Sell
4,005
-200
-5% -$17.8K 0.19% 116
2017
Q2
$305K Hold
4,205
0.17% 121
2017
Q1
$274 Hold
4,205
0.12% 127
2016
Q4
$263K Buy
4,205
+325
+8% +$20.3K 0.16% 125
2016
Q3
$245K Sell
3,880
-350
-8% -$22.1K 0.15% 133
2016
Q2
$262K Buy
4,230
+348
+9% +$21.6K 0.16% 129
2016
Q1
$222K Buy
3,882
+408
+12% +$23.3K 0.16% 127
2015
Q4
$206K Buy
+3,474
New +$206K 0.15% 138
2015
Q3
Sell
-3,447
Closed -$232K 135
2015
Q2
$232K Buy
+3,447
New +$232K 0.17% 135